{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:16:47Z","timestamp":1740107807795,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00774-023-01430-1","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T08:02:08Z","timestamp":1685347328000},"page":"557-566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decrease in osteoporotic fracture in the western Kitakyushu region by the STOP-Fx study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-0849","authenticated-orcid":false,"given":"Yoshiaki","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sabanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukichi","family":"Zenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinako","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiaki","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"key":"1430_CR1","unstructured":"Kitakyushu city, Japan. https:\/\/www.city.kitakyushu.lg.jp\/ho-huku\/file_0487.html. Accessed 1 Dec 2022 (Japanese)"},{"key":"1430_CR2","unstructured":"United Nations, Population Division. https:\/\/population.un.org\/. Accessed 1 Dec 2022"},{"key":"1430_CR3","unstructured":"National Institute of Population and Social Security Research, Simplified inpatient estimates based on population estimates. https:\/\/public.tableau.com\/views\/EstPat2014\/sheet2?:embed=y&:showVizHome=no&:showTabs=y&:display_count=y&:display_static_image=y&:bootstrapWhenNotified=true. Accessed 1 Dec 2022 (Japanese)"},{"key":"1430_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jos.2017.09.008","volume":"23","author":"K Iba","year":"2018","unstructured":"Iba K, Dohke T, Takada J, Sasaki K, Sonoda T, Hanaka M, Miyano S, Yamashita T (2018) Improvement in the rate of inadequate pharmaceutical treatment by orthopaedic surgeons for the prevention of a second fracture over the last 10 years. J Orthop Sci 23:127\u2013131. https:\/\/doi.org\/10.1016\/j.jos.2017.09.008","journal-title":"J Orthop Sci"},{"key":"1430_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11657-015-0231-6","volume":"10","author":"H Kishimoto","year":"2015","unstructured":"Kishimoto H, Maehara M (2015) Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA. Arch Osteoporos 10:231. https:\/\/doi.org\/10.1007\/s11657-015-0231-6","journal-title":"Arch Osteoporos"},{"key":"1430_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11914-010-0009-0","volume":"8","author":"R Dell","year":"2010","unstructured":"Dell R, Greene D (2010) Is osteoporosis disease management cost effective? Curr Osteoporos Rep 8:49\u201355. https:\/\/doi.org\/10.1007\/s11914-010-0009-0","journal-title":"Curr Osteoporos Rep"},{"key":"1430_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB, Milner JR (1973) Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4:643\u2013646. https:\/\/doi.org\/10.1136\/bmj.4.5893.643","journal-title":"Br Med J"},{"key":"1430_CR8","unstructured":"Kitakyushu city, Japan. https:\/\/www.city.kitakyushu.lg.jp\/soumu\/file_0373.html. Accessed 5 Feb 2022 (Japanese)"},{"key":"1430_CR9","unstructured":"Nogata city, Japan. https:\/\/www.city.nogata.fukuoka.jp\/shisei\/_2656\/_2660\/_2970.html. Accessed 5 Feb 2022 (Japanese)"},{"key":"1430_CR10","unstructured":"Ashiya town, Japan. https:\/\/www.town.ashiya.lg.jp\/site\/jinko\/11377.html. Accessed 5 Feb 2022 (Japanese)"},{"key":"1430_CR11","unstructured":"Onga town, Japan. https:\/\/www.town.onga.lg.jp\/soshiki\/9\/1190.html. Accessed 5 Feb 2022 (Japanese)"},{"key":"1430_CR12","unstructured":"Mizumaki town. https:\/\/www.town.mizumaki.lg.jp\/li\/gyosei\/080\/010\/010\/150\/index.html. Accessed 5 Feb 2022 (Japanese)"},{"key":"1430_CR13","unstructured":"British Orthopaedic Association, British Geriatrics Society (2007) The care of patients with fragility fracture, United Kingdom"},{"key":"1430_CR14","unstructured":"Japanese orthopaedic association, Osteoporosis Committee. https:\/\/www.joa.or.jp\/member\/committee\/osteoporosis\/pdf\/femur20.pdf. Accessed 1 Dec 2022 (Japanese)"},{"key":"1430_CR15","unstructured":"Milliman report. https:\/\/jp.milliman.com\/-\/media\/milliman\/importedfiles\/uploadedfiles\/insight\/2019\/client-report-fracture-care-cost.ashx. Accessed 1 Dec 2022 (Japanese)"},{"key":"1430_CR16","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2106\/JBJS.N.01275","volume":"97","author":"HS Bawa","year":"2015","unstructured":"Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97:1555\u20131562. https:\/\/doi.org\/10.2106\/JBJS.N.01275","journal-title":"J Bone Joint Surg Am"},{"key":"1430_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.171.3966.79","volume":"171","author":"JF Myrtle","year":"1971","unstructured":"Myrtle JF, Norman AW (1971) Vitamin D: a cholecalciferol metabolite highly active in promoting intestinal calcium transport. Science 171:79\u201382. https:\/\/doi.org\/10.1126\/science.171.3966.79","journal-title":"Science"},{"key":"1430_CR18","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00198-004-1819-7","volume":"16","author":"R T\u00e4htel\u00e4","year":"2005","unstructured":"T\u00e4htel\u00e4 R, Sepp\u00e4nen J, Laitinen K, Katajam\u00e4ki A, Risteli J, V\u00e4lim\u00e4ki MJ (2005) Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Osteoporos Int 16:1109\u20131116. https:\/\/doi.org\/10.1007\/s00198-004-1819-7","journal-title":"Osteoporos Int"},{"key":"1430_CR19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1359\/JBMR.050403","volume":"20","author":"A Nenonen","year":"2005","unstructured":"Nenonen A, Cheng S, Ivaska KK, Alatalo SL, Lehtim\u00e4ki T, Schmidt-Gayk H, Uusi-Rasi K, Heinonen A, Kannus P, Siev\u00e4nen H, Vuori I, V\u00e4\u00e4n\u00e4nen HK, Halleen JM (2005) Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J Bone Miner Res 20:1804\u20131812. https:\/\/doi.org\/10.1359\/JBMR.050403","journal-title":"J Bone Miner Res"},{"key":"1430_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jbmr.251","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, Wang A, Weryha G, Cummings SR (2011) Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res 26:530\u2013537. https:\/\/doi.org\/10.1002\/jbmr.251","journal-title":"J Bone Miner Res"},{"key":"1430_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","volume":"69","author":"PV Hauschka","year":"1989","unstructured":"Hauschka PV, Lian JB, Cole DE, Gundberg CM (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990\u20131047. https:\/\/doi.org\/10.1152\/physrev.1989.69.3.990","journal-title":"Physiol Rev"},{"key":"1430_CR22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/jbmr.5650081012","volume":"8","author":"SJ Hodges","year":"1993","unstructured":"Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD (1993) Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 8:1241\u20131245. https:\/\/doi.org\/10.1002\/jbmr.5650081012","journal-title":"J Bone Miner Res"},{"key":"1430_CR23","first-page":"1","volume":"921","author":"World Health Organization","year":"2003","unstructured":"World Health Organization (2003) Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 921:1\u2013164","journal-title":"World Health Organ Tech Rep Ser"},{"key":"1430_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00774-013-0490-5","volume":"32","author":"Y Kasukawa","year":"2014","unstructured":"Kasukawa Y, Miyakoshi N, Ebina T, Aizawa T, Hongo M, Nozaka K, Ishikawa Y, Saito H, Chida S, Shimada Y (2014) Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis. J Bone Miner Metab 32:290\u2013297. https:\/\/doi.org\/10.1007\/s00774-013-0490-5","journal-title":"J Bone Miner Metab"},{"key":"1430_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00774-007-0823-3","volume":"26","author":"M Hirao","year":"2008","unstructured":"Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H (2008) Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J Bone Miner Metab 26:260\u2013264. https:\/\/doi.org\/10.1007\/s00774-007-0823-3","journal-title":"J Bone Miner Metab"},{"key":"1430_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jama.285.3.320","volume":"285","author":"R Lindsay","year":"2001","unstructured":"Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320\u2013323. https:\/\/doi.org\/10.1001\/jama.285.3.320","journal-title":"JAMA"},{"key":"1430_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jbmr.4432","volume":"37","author":"L Iconaru","year":"2022","unstructured":"Iconaru L, Charles A, Baleanu F, Surquin M, Benoit F, Mugisha A, Moreau M, Paesmans M, Karmali R, Rubinstein M, Rozenberg S, Body JJ, Bergmann P (2022) Prediction of an imminent fracture after an index fracture\u2014models derived from the Frisbee cohort. J Bone Miner Res 37:59\u201367. https:\/\/doi.org\/10.1002\/jbmr.4432","journal-title":"J Bone Miner Res"},{"key":"1430_CR28","doi-asserted-by":"publisher","first-page":"CD003376","DOI":"10.1002\/14651858.CD003376.pub3","volume":"23","author":"GA Wells","year":"2008","unstructured":"Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 23:CD003376. https:\/\/doi.org\/10.1002\/14651858.CD003376.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1430_CR29","doi-asserted-by":"publisher","first-page":"CD001155","DOI":"10.1002\/14651858.CD001155.pub2","volume":"23","author":"GA Wells","year":"2008","unstructured":"Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 23:CD001155. https:\/\/doi.org\/10.1002\/14651858.CD001155.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1430_CR30","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00198-008-0816-7","volume":"20","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429\u20131437. https:\/\/doi.org\/10.1007\/s00198-008-0816-7","journal-title":"Osteoporos Int"},{"key":"1430_CR31","doi-asserted-by":"publisher","first-page":"CD004523","DOI":"10.1002\/14651858.CD004523.pub3","volume":"3","author":"G Wells","year":"2008","unstructured":"Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 3:CD004523. https:\/\/doi.org\/10.1002\/14651858.CD004523.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1430_CR32","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1359\/JBMR.040325","volume":"19","author":"CH Chesnut 3rd","year":"2004","unstructured":"Chesnut CH 3rd, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241\u20131249. https:\/\/doi.org\/10.1359\/JBMR.040325","journal-title":"J Bone Miner Res"},{"key":"1430_CR33","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Col\u00f3n-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809. https:\/\/doi.org\/10.1056\/NEJMoa074941","journal-title":"N Engl J Med"},{"key":"1430_CR34","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/archinte.162.10.1140","volume":"162","author":"M Maricic","year":"2002","unstructured":"Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD (2002) Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 162:1140\u20131143. https:\/\/doi.org\/10.1001\/archinte.162.10.1140","journal-title":"Arch Intern Med"},{"key":"1430_CR35","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1210\/jc.2013-4175","volume":"99","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Matsumoto T, Sugimoto T, Hosoi T, Miki T, Gorai I, Yoshikawa H, Tanaka Y, Tanaka S, Sone T, Nakano T, Ito M, Matsui S, Yoneda T, Takami H, Watanabe K, Osakabe T, Shiraki M, Fukunaga M (2014) Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab 99:2599\u20132607. https:\/\/doi.org\/10.1210\/jc.2013-4175","journal-title":"J Clin Endocrinol Metab"},{"key":"1430_CR36","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1210\/jc.2011-3479","volume":"97","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y, Fujita T, Shiraki M (2012) Randomized Teriparatide [human parathyroid hormone (PTH) 1\u201334] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 97:3097\u20133106. https:\/\/doi.org\/10.1210\/jc.2011-3479","journal-title":"J Clin Endocrinol Metab"},{"key":"1430_CR37","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.2106\/00004623-200209000-00004","volume":"84","author":"CM Robinson","year":"2002","unstructured":"Robinson CM, Royds M, Abraham A, McQueen MM, Court-Brown CM, Christie J (2002) Refractures in patients at least forty-five years old. A prospective analysis of twenty-two thousand and sixty patients. J Bone Joint Surg Am 84:1528\u20131533. https:\/\/doi.org\/10.2106\/00004623-200209000-00004","journal-title":"J Bone Joint Surg Am"},{"key":"1430_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clinbiomech.2003.08.005","volume":"19","author":"D Hirose","year":"2004","unstructured":"Hirose D, Ishida K, Nagano Y, Takahashi T, Yamamoto H (2004) Posture of the trunk in the sagittal plane is associated with gait in community-dwelling elderly population. Clin Biomech (Bristol, Avon) 19:57\u201363. https:\/\/doi.org\/10.1016\/j.clinbiomech.2003.08.005","journal-title":"Clin Biomech (Bristol, Avon)"},{"key":"1430_CR39","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/00007632-198811000-00019","volume":"13","author":"Y Takemitsu","year":"1988","unstructured":"Takemitsu Y, Harada Y, Iwahara T, Miyamoto M (1988) Miyatake Y (1988) Lumbar degenerative kyphosis Clinical, radiological and epidemiological studies. Spine (Phila Pa 1976) 13:1317\u20131326","journal-title":"Spine (Phila Pa 1976)"},{"key":"1430_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","volume":"28","author":"H Johansson","year":"2017","unstructured":"Johansson H, Siggeirsd\u00f3ttir K, Harvey NC, Od\u00e9n A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA (2017) Imminent risk of fracture after fracture. Osteoporos Int 28:775\u2013780. https:\/\/doi.org\/10.1007\/s00198-016-3868-0","journal-title":"Osteoporos Int"},{"key":"1430_CR41","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00774-021-01208-3","volume":"39","author":"H Hagino","year":"2021","unstructured":"Hagino H, Uemura Y, Mori S, Sone T, Ohta H, Nakamura T (2021) Risk factors for incident vertebral fractures in osteoporosis pharmacotherapy: a 2-year, prospective, observational study. J Bone Miner Metab 39:668\u2013677. https:\/\/doi.org\/10.1007\/s00774-021-01208-3","journal-title":"J Bone Miner Metab"},{"key":"1430_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00198-011-1702-2","volume":"22","author":"PJ Mitchell","year":"2011","unstructured":"Mitchell PJ (2011) Fracture Liaison Services: the UK experience. Osteoporos Int 22:487\u2013494. https:\/\/doi.org\/10.1007\/s00198-011-1702-2","journal-title":"Osteoporos Int"},{"key":"1430_CR43","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jbmr.2180","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH, Patrick AR, Schousboe J, Losina E (2014) The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res 29:1667\u20131674. https:\/\/doi.org\/10.1002\/jbmr.2180","journal-title":"J Bone Miner Res"},{"key":"1430_CR44","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1111\/jgs.17381","volume":"69","author":"S Nayak","year":"2021","unstructured":"Nayak S, Singer A, Greenspan SL (2021) Cost-effectiveness of secondary fracture prevention intervention for Medicare beneficiaries. J Am Geriatr Soc 69:3435\u20133444. https:\/\/doi.org\/10.1111\/jgs.17381","journal-title":"J Am Geriatr Soc"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-023-01430-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T06:07:24Z","timestamp":1689228444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-023-01430-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1007\/s00774-023-01430-1","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board at the University of Occupational and Environmental Health, Fukuoka, Japan (H27-190) and was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}